Where should researchers check primary sources?

Always consult FDA.gov dockets, Federal Register entries, and official letters to industry. News posts here link outward when possible but may lag agency updates.

How does this hub relate to vendor comparison pages?

Regulatory context explains why catalogs shift or documentation tightens; vendor matrices explain retailer-side publishing habits. Use both when modeling procurement risk.

Compliance cluster · Research-only

Research Peptide Regulatory Hub

Navigate federal context, market shocks, and documentation standards without mixing clinical promises into laboratory procurement planning.

2026 regulatory timeline

Interactive chronology of federal milestones affecting laboratory peptide sourcing.

Peptide vendor closures

Market exits, pivots, and what they imply for procurement continuity planning.

FDA peptide reclassification primer

Compound-level discussion of BPC-157, TB-500, CJC-1295, incretin-class materials, and documentation expectations.

RUO labeling overview

How research-use-only positioning interacts with supplier catalogs and institutional oversight.

Peptide regulation news

Rolling coverage when guidance or enforcement shifts vendor behavior.

RUO documentation checklist

Institutional paperwork researchers should maintain before issuing POs.

How to read a peptide COA

Practical literacy for HPLC, MS, and identity fields on certificates of analysis.

Compound research profiles

Deep pages for high-demand peptides with literature anchors and sourcing context.

Regulatory hub FAQ

No. These pages summarize publicly posted regulatory communications and editorial interpretation for laboratories. Qualified counsel and institutional compliance offices should review jurisdiction-specific obligations.